Literature DB >> 18455339

[Kinetics of Pseudomonas aeruginosa virulence gene expression during chronic lung infection in the murine model].

M Pierre1, R Le Berre, H Tiesset, K Faure, B Guery, J-L Desseyn, C Galabert, L Béghin, C Beermann, F Gottrand, M-O Husson.   

Abstract

UNLABELLED: Pseudomonas aeruginosa is a Gram-negative bacillus frequently encountered in human diseases. P. aeruginosa produces a large number of secreted and cell associated virulence factors. Their production is coordinated by various systems of gene regulation. The correlation and sequential intervention of regulation systems during a pulmonary infection have not been determined yet.
OBJECTIVE: The aim of this study was to analyze the expression of three P. aeruginosa virulence genes (exoS, lasI, and algD) during the first seven days of chronic lung infection. To do so, mice were infected intratracheally with agarose beads containing P. aeruginosa.
RESULTS: The results were a progressive decrease of exoS transcription and an increase of algD, and lasI transcription during infection. This dynamic evolution was consistent with the clinical observation, which demonstrated a progressive loss of type III secretion system function and an increase in the mucoid phenotype development in P. aeruginosa strains from cystic fibrosis patients.
CONCLUSION: The development of a P. aeruginosa pulmonary chronic infection associates a decrease of gene expression related to a type III secretion system and an increase of alginate production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455339     DOI: 10.1016/j.medmal.2008.03.001

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  1 in total

1.  Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis.

Authors:  Florence Le Gall; Rozenn Le Berre; Sylvain Rosec; Jeanne Hardy; Stéphanie Gouriou; Sylvie Boisramé-Gastrin; Sophie Vallet; Gilles Rault; Christopher Payan; Geneviève Héry-Arnaud
Journal:  BMC Microbiol       Date:  2013-06-21       Impact factor: 3.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.